293 related articles for article (PubMed ID: 19875288)
1. Coinheritance of Noonan syndrome and Becker muscular dystrophy.
Dinopoulos A; Papadopoulou A; Manta P; Kekou K; Kanelopoulos T; Fretzayas A; Kitsiou S
Neuromuscul Disord; 2010 Jan; 20(1):61-3. PubMed ID: 19875288
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
Anand A; Prabhakar S; Kaul D
Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy.
Pandey GS; Kesari A; Mukherjee M; Mittal RD; Mittal B
Neurol India; 2003 Sep; 51(3):367-9. PubMed ID: 14652441
[TBL] [Abstract][Full Text] [Related]
4. Becker muscular dystrophy caused by an intronic mutation reducing the efficiency of the splice donor site of intron 26 of the dystrophin gene.
Baskin B; Banwell B; Khater RA; Hawkins C; Ray PN
Neuromuscul Disord; 2009 Mar; 19(3):189-92. PubMed ID: 19230662
[TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
den Dunnen JT; de Visser M; Bakker E
Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
[TBL] [Abstract][Full Text] [Related]
6. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
7. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
[TBL] [Abstract][Full Text] [Related]
8. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
[TBL] [Abstract][Full Text] [Related]
9. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
[TBL] [Abstract][Full Text] [Related]
10. Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis.
Kumari D; Mital A; Gupta M; Goyle S
Neurol India; 2003 Jun; 51(2):223-6. PubMed ID: 14571009
[TBL] [Abstract][Full Text] [Related]
11. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
Pradhan S
Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
[TBL] [Abstract][Full Text] [Related]
12. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
[TBL] [Abstract][Full Text] [Related]
13. [The heartache of muscular dystrophy].
Hoogerwaard EM; Ginjaar HB; Wilde AA; Leschot NJ; de Voogt WG; de Visser M
Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2181-4. PubMed ID: 11103252
[TBL] [Abstract][Full Text] [Related]
14. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
[TBL] [Abstract][Full Text] [Related]
15. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
Matsuo M
IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for Duchenne and Becker dystrophies.
Voisin V; de la Porte S
Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
[TBL] [Abstract][Full Text] [Related]
17. PGD for dystrophin gene deletions using fluorescence in situ hybridization.
Malmgren H; White I; Johansson S; Levkov L; Iwarsson E; Fridström M; Blennow E
Mol Hum Reprod; 2006 May; 12(5):353-6. PubMed ID: 16608904
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between genotypes and phenotypes in pseudohypertrophic muscular dystrophy].
Feng SW; Liang YY; Cao JQ; Song XM; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):653-7. PubMed ID: 23225043
[TBL] [Abstract][Full Text] [Related]
19. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.
Aartsma-Rus A; Van Deutekom JC; Fokkema IF; Van Ommen GJ; Den Dunnen JT
Muscle Nerve; 2006 Aug; 34(2):135-44. PubMed ID: 16770791
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.
Daoud F; Angeard N; Demerre B; Martie I; Benyaou R; Leturcq F; Cossée M; Deburgrave N; Saillour Y; Tuffery S; Urtizberea A; Toutain A; Echenne B; Frischman M; Mayer M; Desguerre I; Estournet B; Réveillère C; Penisson-Besnier ; Cuisset JM; Kaplan JC; Héron D; Rivier F; Chelly J
Hum Mol Genet; 2009 Oct; 18(20):3779-94. PubMed ID: 19602481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
